Paper · 2002 · Open access

Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure

SSC Koch, LH Thoresen, JG Tikhe, KA Maegley, RJ Almassy, JK Li, XH Yu, SE Zook, RA Kumpf, C Zhang, TJ Boritzki, RN Mansour and 13 more

Newcastle University ePrints (Newcastle Univesity) · Published 31 December 2002 · DOI 10.25405/ncl.34649619

Open full textCite this paper

In brief

“Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure” is a 2002 paper by SSC Koch and 24 co-authors, published in Newcastle University ePrints (Newcastle Univesity). OpenAlex counts 0 citations as of 19 November 2026. It is open access: the full text is free to read at Newcastle University ePrints (Newcastle Univesity).

Citations
0
Authors
25

Abstract

A series of novel compounds have been designed that are potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1), and the activity and physical properties have been characterized. The new structural classes, 3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-6-ones and 3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-ones, have conformationally locked benzamide cores that specifically interact with the PARP-1 protein. The compounds have been evaluated with in vitro cellular assays that measure the ability of the PARP-1 inhibitors to enhance the effect of cytotoxic agents against cancer cell lines.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Koch, S., Thoresen, L., Tikhe, J., Maegley, K., Almassy, R., Li, J., Yu, X., Zook, S., Kumpf, R., Zhang, C., Boritzki, T., Mansour, R., Zhang, K., Ekker, A., Calabrese, C., Curtin, N. J., Kyle, S., Thomas, H. D., Wang, L., . . . Hostomsky, Z. K. S. (2002). Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. Newcastle University ePrints (Newcastle Univesity). https://doi.org/10.25405/ncl.34649619

MLA 9

Koch, SSC, et al. “Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure.” Newcastle University ePrints (Newcastle Univesity), 2002. https://doi.org/10.25405/ncl.34649619.

Chicago

Koch, SSC, LH Thoresen, JG Tikhe, KA Maegley, RJ Almassy, JK Li, XH Yu, et al. 2002. “Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure.” Newcastle University ePrints (Newcastle Univesity). https://doi.org/10.25405/ncl.34649619.

Harvard

Koch, S. et al. (2002) ‘Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure’, Newcastle University ePrints (Newcastle Univesity). doi:10.25405/ncl.34649619.

IEEE

S. Koch et al., “Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure,” Newcastle University ePrints (Newcastle Univesity), 2002, doi: 10.25405/ncl.34649619.

BibTeX

@article{koch2002novel,
  title     = {{Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure}},
  author    = {Koch, SSC and Thoresen, LH and Tikhe, JG and Maegley, KA and Almassy, RJ and Li, JK and Yu, XH and Zook, SE and Kumpf, RA and Zhang, C and Boritzki, TJ and Mansour, RN and Zhang, KE and Ekker, A and Calabrese, CR and Curtin, Nicola J. and Kyle, Suzanne and Thomas, Huw D. and Wang, LZ and Calvert, Alan and Golding, Bernard and Griffin, R. J. and Newell, David and Webber, SE and Hostomsky, Z. K. S.},
  journal   = {Newcastle University ePrints (Newcastle Univesity)},
  year      = {2002},
  doi       = {10.25405/ncl.34649619},
  url       = {https://doi.org/10.25405/ncl.34649619}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy

  • PARP-1 inhibitors
  • PARP1
  • anticancer agents
  • cancer cell lines

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Koch, S., Thoresen, L., Tikhe, J., Maegley, K., Almassy, R., Li, J., Yu, X., Zook, S., Kumpf, R., Zhang, C., Boritzki, T., Mansour, R., Zhang, K., Ekker, A., Calabrese, C., Curtin, N. J., Kyle, S., Thomas, H. D., Wang, L., . . . Hostomsky, Z. K. S. (2002). Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. Newcastle University ePrints (Newcastle Univesity). https://doi.org/10.25405/ncl.34649619

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Newcastle University ePrints (Newcastle Univesity): sign in and open the full text from this page.

Who wrote this paper?

SSC Koch, LH Thoresen, JG Tikhe, KA Maegley, RJ Almassy, JK Li, XH Yu, SE Zook, RA Kumpf, C Zhang, TJ Boritzki, RN Mansour and 13 more.

What is the DOI of this paper?

10.25405/ncl.34649619, permanently at https://doi.org/10.25405/ncl.34649619. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.